Compound ID | 1571
Class: CaSR antagonist
Spectrum of activity: | Gram-positive |
Details of activity: | Antimicrobial activity against Staphylococcus aureus and MRSA |
Institute where first reported: | Department of Medicinal Chemistry, Chengdu, China |
Year first mentioned: | 2019 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://www.nature.com/articles/s41429-019-0177-9 |